Emanuele Durante Mangoni
Emanuele Durante Mangoni
University of Campania L. Vanvitelli
Email verificata su
Citata da
Citata da
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, ...
The lancet Infectious diseases 18 (4), 391-400, 2018
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A …
E Durante-Mangoni, G Signoriello, R Andini, A Mattei, M De Cristoforo, ...
Clinical infectious diseases 57 (3), 349-358, 2013
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study
A Nobili, G Licata, F Salerno, L Pasina, M Tettamanti, C Franchi, ...
European journal of clinical pharmacology 67, 507-519, 2011
Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study
E Durante-Mangoni, S Bradley, C Selton-Suty, MF Tripodi, B Barsic, ...
Archives of internal medicine 168 (19), 2095-2103, 2008
European heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by …
C Blomström-Lundqvist, V Traykov, PA Erba, H Burri, JC Nielsen, ...
European Journal of Cardio-Thoracic Surgery 57 (1), e1-e31, 2020
Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices
E Athan, VH Chu, P Tattevin, C Selton-Suty, P Jones, C Naber, JM Miró, ...
Jama 307 (16), 1727-1735, 2012
Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis
LE Adinolfi, MG Giordano, A Andreana, MF Tripodi, R Utili, G Cesaro, ...
British journal of haematology 113 (3), 590-595, 2001
Do we still need the aminoglycosides?
E Durante-Mangoni, A Grammatikos, R Utili, ME Falagas
International journal of antimicrobial agents 33 (3), 201-205, 2009
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis
T Lalani, VH Chu, LP Park, E Cecchi, GR Corey, E Durante-Mangoni, ...
JAMA internal medicine 173 (16), 1495-1504, 2013
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis
VH Chu, LP Park, E Athan, F Delahaye, T Freiberger, C Lamas, JM Miro, ...
Circulation 131 (2), 131-140, 2015
Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure
T Kiefer, L Park, C Tribouilloy, C Cortes, R Casillo, V Chu, F Delahaye, ...
Jama 306 (20), 2239-2247, 2011
Combination therapy for carbapenem-resistant Gram-negative bacteria
M Paul, Y Carmeli, E Durante-Mangoni, JW Mouton, E Tacconelli, ...
Journal of Antimicrobial Chemotherapy 69 (9), 2305-2309, 2014
Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance
E Durante-Mangoni, R Zarrilli
Future microbiology 6 (4), 407-422, 2011
Management of carbapenem-resistant Enterobacteriaceae infections
E Durante-Mangoni, R Andini, R Zampino
Clinical Microbiology and Infection 25 (8), 943-950, 2019
Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis
S Leone, V Ravasio, E Durante-Mangoni, M Crapis, G Carosi, PG Scotton, ...
Infection 40, 527-535, 2012
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor‐α in chronic hepatitis C patients
E DURANTE‐MANGONI, R Zampino, A Marrone, MF TRIPODI, L Rinaldi, ...
Alimentary pharmacology & therapeutics 24 (9), 1349-1357, 2006
Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells
E Durante-Mangoni, RJ Wang, A Shaulov, Q He, I Nasser, N Afdhal, ...
The Journal of Immunology 173 (3), 2159-2166, 2004
Risk factors for “major” embolic events in hospitalized patients with infective endocarditis
ED Mangoni, LE Adinolfi, MF Tripodi, A Andreana, M Gambardella, ...
American heart journal 146 (2), 311-316, 2003
Validated risk score for predicting 6‐month mortality in infective endocarditis
LP Park, VH Chu, G Peterson, A Skoutelis, T Lejko‐Zupa, E Bouza, ...
Journal of the American Heart Association 5 (4), e003016, 2016
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates …
MF Tripodi, E Durante-Mangoni, R Fortunato, R Utili, R Zarrilli
International journal of antimicrobial agents 30 (6), 537-540, 2007
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20